Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-013320
Filing Date
2024-10-15
Accepted
2024-10-15 17:16:35
Documents
59
Period of Report
2024-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q cydy-20240831x10q.htm   iXBRL 10-Q 1286317
2 EX-31.1 cydy-20240831xex31d1.htm EX-31.1 9290
3 EX-31.2 cydy-20240831xex31d2.htm EX-31.2 9435
4 EX-32 cydy-20240831xex32.htm EX-32 7855
  Complete submission text file 0001558370-24-013320.txt   5533520

Data Files

Seq Description Document Type Size
5 EX-101.SCH cydy-20240831.xsd EX-101.SCH 46955
6 EX-101.CAL cydy-20240831_cal.xml EX-101.CAL 45303
7 EX-101.DEF cydy-20240831_def.xml EX-101.DEF 156920
8 EX-101.LAB cydy-20240831_lab.xml EX-101.LAB 313463
9 EX-101.PRE cydy-20240831_pre.xml EX-101.PRE 263235
62 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20240831x10q_htm.xml XML 920087
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 241372680
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)